HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming-Chung Jiang Selected Research

Growth Factor Receptors

6/2015Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.
10/2014Inverse correlation of phospho-KDR/Flk-1 expression and stage of colorectal cancer: implication of the significance of neoangiogenesis in activated VEGFR-2 expressing early stage colorectal adenocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming-Chung Jiang Research Topics

Disease

18Neoplasms (Cancer)
10/2016 - 03/2005
7Melanoma (Melanoma, Malignant)
11/2016 - 05/2009
7Neoplasm Metastasis (Metastasis)
10/2016 - 07/2008
4Colorectal Neoplasms (Colorectal Cancer)
06/2015 - 04/2010
2Colonic Neoplasms (Colon Cancer)
06/2015 - 08/2009
2Breast Neoplasms (Breast Cancer)
10/2013 - 10/2010
2Carcinoma (Carcinomatosis)
10/2013 - 10/2012
1Adenocarcinoma
10/2014
1Adenoma (Adenomas)
10/2014
1Stroke (Strokes)
01/2010
1Cerebral Hemorrhage
01/2010

Drug/Important Bio-Agent (IBA)

9Cellular Apoptosis Susceptibility ProteinIBA
10/2016 - 03/2008
7Proteins (Proteins, Gene)FDA Link
10/2016 - 01/2008
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2013 - 12/2012
2Microphthalmia-Associated Transcription FactorIBA
11/2016 - 10/2016
2Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
11/2016 - 10/2016
2Small Interfering RNA (siRNA)IBA
11/2016 - 09/2013
2Biomarkers (Surrogate Marker)IBA
10/2016 - 10/2013
2Growth Factor ReceptorsIBA
06/2015 - 10/2014
2Peptide Hydrolases (Proteases)FDA Link
12/2012 - 07/2008
2Matrix Metalloproteinases (MMPs)IBA
12/2012 - 08/2009
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2010 - 03/2008
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2008 - 01/2008
2Cisplatin (Platino)FDA LinkGeneric
03/2008 - 01/2008
2Fluorouracil (Carac)FDA LinkGeneric
03/2008 - 01/2008
2TamoxifenFDA LinkGeneric
03/2008 - 01/2008
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2016
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
11/2016
1Protein Kinases (Protein Kinase)IBA
11/2016
1Immunoconjugates (Immunoconjugate)IBA
10/2016
1Indicators and Reagents (Reagents)IBA
10/2016
1Sunitinib (Sutent)FDA Link
06/2015
1VemurafenibIBA
06/2015
1Lapatinib (GW572016)FDA Link
06/2015
1Phosphotransferases (Kinase)IBA
06/2015
1Sorafenib (BAY 43-9006)FDA Link
06/2015
1Mitogen-Activated Protein Kinase 3IBA
01/2015
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2014
1Membrane Proteins (Integral Membrane Proteins)IBA
12/2012
1TubulinIBA
10/2010
1Carcinoembryonic AntigenIBA
04/2010
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2009
1GelatinIBA
08/2009
1Prostaglandins FIBA
08/2009
1ProstaglandinsIBA
08/2009
1Conditioned Culture MediaIBA
05/2009
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
07/2008
1matrigelIBA
07/2008
1Paclitaxel (Taxol)FDA LinkGeneric
03/2008
1DNA (Deoxyribonucleic Acid)IBA
03/2005

Therapy/Procedure

3Therapeutics
10/2016 - 12/2012
3Drug Therapy (Chemotherapy)
08/2010 - 01/2008
1Quantum Dots (Quantum Dot)
12/2012